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Abstract 
Afadin, the protein coded by AFDN (6q27), also 
known as AF6 or MLLT4, is a cytoskeletal and 
junction-associated protein that links nectins, 
transmembrane proteins, to the F-actin (actin 
cytoskeleton) in a type of cell-cell junctions: the 
adherens junctions (AJs). Afadin plays an important 
role in AJs integrity and apical-basal polarity. There 
is growing evidence of it's role in carcinogenesis. 
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Identity 
HGNC (Hugo): AFDN 
Location: 6q27 
Other names: MLLT4, AF6 
Figure 1 Localization of AFDN (also called AF6 or MLLT4) 
- Courtesy Mariano Rocchi. 
DNA/RNA 
Description 
The AFDN gene, located on 6q27, has a genomic 
size of 145,030 bases and encodes for several 
transcripts on the position chr6:167826991-
167972020 in the + strand. 
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Figure 2 Afadin protein 
 
Transcription 
According to RefSeq, there are 3 transcripts (see 
below) and an anti-sens (NR_027906)  
AFDN at chr6:167826991-167972020 - 
(NM_001207008) afadin isoform 1: 7,459 bp  
AFDN at chr6:167826991-167965113 - 
(NM_001040000) afadin isoform 2: 7,629 bp  
AFDN at chr6:167827635-167972020 - 




The AFDN gene codes for the afadin protein.  
From N-term to C-term, afadin possess two Ras-
association (RA) domains, a forkhead-associated 
(FHA) domain, a DIL domain (responsible for actin 
stress fiber formation (Saito et al., 2015)), a PDZ 
domain (responsible for binding the cytoplasmic C-
terminus of nectins; where TJP1 (ZO-1) also binds 
(Kuriyama et al., 1996)), three proline-rich (PR) 
domains, one of which interacts with USP9X 
(FAM): (aa 1130-1612) (Hock et al., 199; Taya et al., 
1998), and an F-actin-binding domain (see Figure 2).  





(Prasad et al., 1993).  
Phosphorylation sites: KERQRLFSQG (aa 1792-
1801 according to UniProt). There is an AKT 
phosphorylation site at Ser1718 in l-Afadin (large 
variant, see below). Phosphorylation of l-Afadin by 
AKT at Ser1718 promotes nuclear localization, 
which enhances migration and perturbs cell to cell 
adhesion (Ellol et al. 2014).  
Afadin has many splice variants, in particular two of 
them: the larger l-afadin and the smaller s-afadin. s-
Afadin lacks the F-actin-binding domain and the 
third proline-rich domain. These variants are made 
of 1612 to 1816 amino acids (aa) according to 
UniProt, or 1655 and 1829 aa according to others 
(see Figure 2).  
l-Afadin links nectins to actin filaments (F-actin). 
Through its PDZ domain, l-Afadin binds to the 
nectin conserved motif of four amino acid residues 
(Glu/Ala-X-Tyr-Val) (except for nectin-4), and F-
actin through its F-actin-binding domain. Afadin 
binds nectins (NECTIN1, NECTIN2, NECTIN3, 
NECTIN4), but not nectin-like molecules (Necls: 
CADM1, CADM2, CADM3, CADM4, PVR) 
(Review in Ogita and Takai, 2006). 
Afadin forms homodimer.  
The 3 main isoforms produced by alternative 
splicing are: 
Canonic sequence (Isoform 4, identifier: P55196-4). 
1,824 amino acids; 206,804 Da.  
s-afadin (Isoform 1, identifier: P55196-2); 1,612 aa; 
182,000 Da. Compared to the canonical sequence, 
are missing aa: 139, 393-407, 1605-1628, 1629-
1824.  
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Figure 3 Nectin/Afadin: nectin activations. 
 
l-afadin (Isoform 2, identifier: P55196-1); 1,816 aa; 
205,605 Da. Compared to the canonical sequence, 
are missing aa: 139, 393-407, 1048-1048, 1747-
1824. 
Expression 
L-afadin is widely expressed in epithelial cells, while 
s-afadin expression is restricted to the brain (Buchert 
et al., 2007) 
Localisation 
Afadin is mainly located at the cell junctions named 
adherens junctions. s-afadin is able to localize both 
to the plasma membrane or to the nucleus while l-
afadin was said to be unable to localize to the nucleus 
(Buchert et al., 2007). 
Function 
Epithelial cells contain three types of cell-cell 
junction: tight junctions, localized in the apex of the 
cells, adherens junctions (AJs), and desmosomes.  
Adherens junctions:  two types of cell adhesion 
molecules (CAMs), cadherins and nectins, interact 
with actin filaments (F-actin). They interact through 
their cytoplasmic domain to form adherens 
junctions. 
Cadherins and nectins:  In epithelial cells, β-
catenin (CTNNB1) directly binds to cadherins and 
links it to the actin cytoskeleton through &alpha-
catenin (CTNNA1, CTNNA2, CTNNA3), while 
nectins are linked to the actin cytoskeleton through 
afadin (Tachibana et al., 2000; Ogita and Takai, 
2006) (see Figure 4). 
Nectins first activate SRC. Activated SRC then 
activates/phosphorylates FARP2, and VAV2. SRC 
also activates RABGEF1 (also known as Rap1) 
through CRK and RAPGEF1 (C3G).  
Activated RABGEF1 (Rap1) also activates FARP2, 
which activates CDC42 40012. Activated CDC42 
induces the activation of VAV2, followed by the 
activation of RAC1 (RAC) (see Figure 3). 
Activated RABGEF1 (Rap1) is essential for down-
regulation of Rho signaling and actin stress fiber 
dissolution (Birukova et al., 2013). 
Some of the downstream effectors for VAV2 and 
RAC1 are actin filaments (F-actin)-binding proteins.  
Nectins associate with cadherins through the 
interaction of afadin with alpha-catenin and: a 
ponsin ( SORBS1) - vinculin (VCL) unit, an SSX2IP  
(ADIP) - a-actinin ( ACTN1, ACTN2 and ACTN3) 
unit, and a LMO7 - a-actinin unit (see Figure 4). 
RABGEF1 (Rap1) activates afadin to interacts with 
CTNND1  (p120 catenin) and strengthens its binding 
to E-cadherin ( CDH1), which results in reduced E-
cadherin endocytosis (Bégay-Müller et al., 2002; 
Kooistra et al. 2007; Sakisaka et al., 2007 ; Birukova 
et al., 2013; Takeichi 2014)  
Tight junctions/role of ZO-1 Afadin also associates 
transiently with tight junction protein TJP1 (ZO-1). 
ZO-1 is a member of F-actin-binding ZO proteins, 
which bind CAMs of tight junctions (TJs) such as 
claudins, occludin ( OCLN), and junctional adhesion 
molecules (JAMs) and link them to the actin 
cytoskeleton (Sakisaka et al., 2007) (see Figure 4). 
Occludin, EPHA2, a transmembrane tyrosine kinase 
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receptor, and afadin also cooperate in tight junction 
organization (Perez White et al., 2017). Afadin is 
therefore a peripheral component of tight junctions 
in epithelial cells. The binding of claudins to tight 
junction proteins (or zonula occludens ZOs) and 
afadin and other proteins constitutes a step in cellular 
signal transduction (Zhang et al., 2018).  
Apico-basal polarization/role of Par-3:  PARD3 
(Par-3), Par-6 and atypical protein kinase C (PRKCI) 
are required for apico-basal polarization of epithelial 
cells. Nectin-1 and nectin-3, but not nectin-2, bind 
the PDZ domain of Par-3 (Rakotomamonjy et al., 
2017)  
1- Par-3 regulates association of afadin with trans-
interacting nectin and the formation of AJs; 
2- Par-3 regulates E-cadherin-induced activation of 
Rac and formation of AJs;  
3- Par-3 and afadin cooperatively regulate nectin-
induced formation of TJs (Sakisaka et al 2007)  
 Migration  Afadin is localized at cell-cell contact 
sites in mesangial cells. Afadin forms a complex 
with CTNNB1 (β-catenin) in cultured mesangial 
cells and Afadin regulates migratory polarity 
(Tsurumi et al., 2016). Afadin is required for the 
maintenance of the radial glial scaffold for neuronal 
migration during cortical development (Yamamoto 
et al., 2015b).  
Mitotic spindle orientation  Afadin is required for 
mitotic spindle orientation and correct epithelial 
morphogenesis (Carminati et al., 2016). Afadin 
orients the mitotic spindle and is required for lumen 
continuity in developing renal tubules by orienting 
the mitotic spindle during cell division (Gao et al., 
2017). Afadin controls cell polarization and mitotic 
spindle orientation in developing cortical radial glia 
(Rakotomamonjy et al., 2017). 
Actin polymerization/profilin profilin plays an 
important role in actin polymerization. Profilin 1 and 
Profilin 2 (PFN1 and PFN2) are afadin-binding 
protein (Boettner B et al., 2000)  
MAPK cascade Afadin interacts with HRAS, 
KRAS, and NRAS GTPases and the Ras-related 
RAP1A leading to MAPK activation (Yamamoto et 
al., 1997). MRAS, whose GTP/GDP cycle is 
sensitive to the Ras GEFs, SOS1 42355, and 
RASGRF1 43453 (GRF1) and to RASA1 (p120 
RASGAP) interacts with Afadin (Quilliam et al. 
1999). RRAS, RRAS2 also interact with Afadin 
(Linnemann et al., 1999). Afadin also acts 
downstream of EGFR-Ras and provides a link from 
EGFR to cytoskeletal elements in the cell motility 
process (Gaengel and Mlodzik 2003).  
Ubiquitination Afadin is a substrate of the USP9X 
deubiquitinating enzyme. USP9X can release 
ubiquitin from Afadin (Taya et al., 1998). 
Ephrin receptors Eph receptor tyrosine kinases are 
membrane-bound proteins implicated in cell 
migration and intercellular communication during 
embryonic development, regulating cell pattern 
formation during organogenesis. EPHA7, EPHB2, 
EPHB3, and EPHB6 interact with Afadin. Afadin is 
phosphorylated specifically by EPHB3 and EPHB2 
(Hock et al., 1998) 
Homology 
Homologs of the AFDN gene: The AFDN gene is 
conserved in chimpanzee, Rhesus monkey, dog, 
cow, mouse, rat, chicken, zebrafish, C.elegans, and 
frog (Orthologs from Annotation Pipeline: 201 
organisms have orthologs with human gene AFDN). 
Implicated in 
Top note 
AFDN is implicated in a few translocations and/or 
fusion genes, in particular in the t(6;11) seen in 
leukemia (see Figure 5). 
Down regulation of afadin appears to drive to 




Acute myeloid leukemia (AML) and acute 
lymphoblastic leukemia (ALL) of children and 
adults. Translocation t(6;11) represent about 5% of 
acute leukemia with 11q23/KMT2A rearrangement 
and is more frequent in AML than in ALL (Prasad et 
al., 1993; review in Huret 2018). 
Prognosis 
The prognosis is poor. 
Cytogenetics 
may be overlooked; The t(6;11) is the sole 
abnormality in most cases, but may be accompanied 
with, +8, +19 and+21. 
Hybrid/Mutated gene 
5' KMT2A- 3' AFDN 
Abnormal protein 
NH2-term KMT2A (with the AT hook and DNA 
binding motifs) is fused to most of AFDN. 
KMT2A/AFDN, through constitutive self-
association and in cooperation with the histone-
methyltransferase DOT1L, activates aberrant gene 
expression (Deshpande et al., 2013). 
KMT2A/AFDN directly upregulates BHLHE41 
(SHARP1) by DOT1L. SHARP1 binds to 
transcriptionally active chromatin. Suppression of 
SHARP1 induces robust apoptosis. The circadian 
clock transcription factor SHARP1 as an oncogenic 
target in KMT2A/AFDN cells (Numata et al., 2018).  
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Figure 4 Afadin in adherens junctions ( AJ) and tight junctions ( TJ) 
 
AFDN is expressed in the cytoplasm of normal cells 
and controls RAS levels. By contrast, in 
KMT2A/AFDN localize in the nucleus, leading to 
aberrant activation of RAS and of its downstream 
targets (Joh et al. 1997). 
Breast carcinoma 
In breast cancer, loss of afadin protein expression 
induces cell migration and cell invasion (Yamamoto 
et al., 2015a), and is associated with adverse 
prognosis (Letessier et al., 2007; Fournier et al., 
2011). Afadin loss of expression (in 15% of breast 
carcinoma) is also associated with an increased risk 
of metastatic relapse (Fournier et al., 2011).  
The nuclear localization of L-Afadin, regulated by 
phosphorylation at Ser1718 by the Akt pathway, is 
clinically relevant for breast cancer progression 
(Ellol et al. 2014).  
The fusion gene AFDN/ KCNAB1 has been found in 
breast adenocarcinoma (Yoshihara et al., 2015).  
The fusion gene AFDN/ HMGCLL1 has also been 
found in breast adenocarcinoma (Hu et al. 2018). 
Uterus cancer 
Afadin expression was significantly associated with 
myometrial invasion and high histological grade in 
uterine corpus endometrial carcinoma (Yamamoto et 
al., 2015a).  
The fusion gene ATG5/AFDN has been found in 
uterine carcinosarcoma (Hu et al. 2018). 
Ovarian serous cystadenocarcinoma 
The fusion gene AFDN/ UNC93A has been found in 
ovarian serous cystadenocarcinoma (Yoshihara et 
al., 2015). 
Prostate adenocarcinoma 
The fusion gene AFDN/ EXOC6B has been found in 
prostate adenocarcinoma (Yoshihara et al., 2015).  
The fusion gene AFDN/ SYK has also been found in 
prostate adenocarcinoma (Hu et al. 2018). 
Clear cell renal cell carcinoma 
The fusion gene AFDN/ TTLL2 has been found in 
clear cell renal cell carcinoma (Hu et al. 2018). 
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Colon cancer 
Lower expression of CFTR and/or afadin is 
correlated with a poor prognosis in colon cancer 
(Sun et al., 2014). Loss of afadin induces cell 
migration and cell invasion (Yamamoto et al., 
2015a). 
Pancreatic cancer. 
Afadin is expressed at low levels in pancreatic 
cancer. Depletion of Afadin promotes proliferation 
through upregulation of the expression of SNAIL 
proteins, and this requires the nuclear localization of 
afadin (Xu et al., 2015). 
Gastric cancer 
Helicobacter pylori disrupts cell-cell junctions 
through down regulation of afadin and induces 
epithelial to mesenchymal transition (EMT) of 
gastric cells, leading to the acquisition of an 
aggressive phenotype, which can contribute to 
gastric carcinogenesis (Marques et al., 2018).  
AFDN antisense RNA 1 ( AFDN-AS1) is 
significantly downregulated in gastric cancer and a 
predictor of a poor prognosis (Lai et al., 2017). 
Low grade glioma 
The fusion gene AFDN/ SASH1 has been found in 
low grade glioma (Yoshihara et al., 2015). 
Osteosarcoma 
High expression of CLDN2 (claudin2) induces high 
expression of afadin, which results in silencing of the 
MAPK signaling pathway and inhibits the metastasis 
phenotype in osteosarcoma cells (Zhang et al., 
2018). 
Lung squamous cell carcinoma 
The fusion gene AFDN/ GMDS has been found in 
squamous cell carcinoma of the lung (Hu et al. 
2018). 
Neurone synapse and nucleus 
Afadin signaling at synapses contributes to activity-
dependent spine morphogenic activity. Following 
stimulation by 17β-estradiol, afadin locates to both 
synapses and the nucleus. Accumulation of afadin in 
the nucleus induces phosphorylation of kinases 
MAPK3 / MAPK1 (pERK1/2), phosphorylation of 
RPS6KA1 (p90RSK) that can directly phosphorylate 
histone H3 at serine 10 (H3S10p.). This in turn 
contributes to long term alterations in synapse 
structure (VanLeeuwen et al., 2014; Sellers et al., 
2018). 
Breakpoints 
See Figure 5. 
 
 
Figure 5  ADFN fusion partners. 
 
 






Atlas Genet Cytogenet Oncol Haematol. 2019; 23(8) 222 
 
To be noted 
TARGET THERAPY 
Targeting the DVL2 - FOXE1 -Snail signalling axis 
may thus represent a promising therapeutic strategy 
(Xu et al., 2015)  
Exposure of KMT2A/AFDN -rearranged AML 
blasts to tipifarnib, a RAS inhibitor, leads to cell 
autophagy and apoptosis, thus supporting RAS 
targeting as a novel potential therapy (Manara et al. 
2014). 
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